Your browser doesn't support javascript.
loading
Consensus criteria for chronic rhinosinusitis disease control: an international Delphi Study.
Sedaghat, A R; Fokkens, W J; Lund, V J; Hellings, P W; Kern, R C; Reitsma, S; Toppila-Salmi, S; Bernal-Sprekelsen, M; Mullol, J; Gevaert, P; Teeling, T; Alobid, I; Anselmo-Lima, W T; Baroody, F M; Cervin, A; Cohen, N A; Constantinidis, J; De Gabory, L; Desrosiers, M; Harvey, R J; Kalogjera, L; Knill, A; Landis, B N; Meco, C; Philpott, C M; Ryan, D; Schlosser, R J; Senior, B A; Smith, T L; Tomazic, P V; Zhang, L; Hopkins, C.
Afiliação
  • Sedaghat AR; Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Fokkens WJ; Department of Otorhinolaryngology and Head and Neck Surgery, Amsterdam University Medical Centres, location AMC, Amsterdam, The Netherlands.
  • Lund VJ; Royal National ENT Hospital, University College London Hospital NHS Foundation Trust, London, UK.
  • Hellings PW; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospitals Leuven, KU Leuven, Belgium.
  • Kern RC; Department of Otorhinolaryngology, Head and Neck Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
  • Reitsma S; Department of Otorhinolaryngology and Head and Neck Surgery, Amsterdam University Medical Centres, location AMC, Amsterdam, The Netherlands.
  • Toppila-Salmi S; Department of Otorhinolaryngology, Kuopio University Hospital and University of Eastern Finland, Finland and Department of Allergy, Inflammation Center, Helsinki University Hospital and University of Helsinki, Finland.
  • Bernal-Sprekelsen M; Department of ORL, Hospital Clinic, University of Barcelona, Spain.
  • Mullol J; Rhinology Unit and Smell Clinic, ENT Department, Hospital Clinic, FRCB-IDIBAPS, Universitat de Barcelona, CIBERES, Barcelona, Catalonia, Spain.
  • Gevaert P; Department of Otorhinolaryngology, Ghent University, Ghent, Belgium.
  • Teeling T; Patient representative, Task Force Healthcare, WTC Den Haag, The Netherlands.
  • Alobid I; Rhinology and Skull Base Unit, ENT Department, Hospital Clinic, Universitat de Barcelona, August Pi i Sunyer Biomedical Research Institute, CIBERES, Barcelona, Spain.
  • Anselmo-Lima WT; Division of Otorhinolaryngology, Department of Ophthalmology, Otorhinolaryngology, Head and Neck Surgery, Ribeirao Preto Medical School-University of Sao Paulo, Sao Paulo, Brazil.
  • Baroody FM; Department of Otorhinolaryngology-Head and Neck Surgery, The University of Chicago Medicine and the Comer Children’s Hospital, Chicago, IL, USA.
  • Cervin A; Department of Otorhinolaryngology, Head and Neck Surgery, Royal Brisbane and Women's Hospital; Faculty of Medicine, University of Queensland, Brisbane, Australia and Department of Clinical Sciences, Lund University, Lund, Sweden.
  • Cohen NA; Department of Otorhinolaryngology - Head and Neck Surgery, Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA, USA.
  • Constantinidis J; 1st Department of ORL, Head and Neck Surgery, Aristotle University, AHEPA Hospital, Thessaloniki, Greece.
  • De Gabory L; Rhinology and Plastic Surgery Unit, Otorhinolaryngology, Head and Neck Surgery and Pediatric ENT Department, CHU ux, Hospital Pellegrin, Centre F-X Michelet, Bordeaux, France.
  • Desrosiers M; Department of ORL-HNS, Universitat de Montreal, Montreal, Canada.
  • Harvey RJ; Rhinology and Skull Base Department, Applied Medical Research Centre, UNSW (Conjoint) and Macquarie University (Clinical), Sydney, Australia.
  • Kalogjera L; Department of Otorhinolaryngology/Head and Neck Surgery, Zagreb School of Medicine; University Hospital Center, Sestre milosrdnice,Zagreb, Croatia.
  • Knill A; Patient representative, Sinus UK, London, UK.
  • Landis BN; Rhinology-Olfactology Unit, Otorhinolaryngology Department, University Hospital of Geneva, Geneva, Switzerland.
  • Meco C; Department of Otorhinolaryngology, Head and Neck Surgery, Ankara University, Ankara, Turkey and Department of Otorhinolaryngology, Head and Neck Surgery, Salzburg Paracelsus Medical University, Salzburg, Austria.
  • Philpott CM; Rhinology and ENT Research Group, Norwich Medical School, University of East Anglia, Norwich, UK and Norfolk and Waveney ENT Service, James Paget University Hospital, Great Yarmouth and Norfolk and Norwich University Hospital, Norwich, UK.
  • Ryan D; Allergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, Scotland, UK and International Primary Care Respiratory Group, Edinburgh, Scotland, UK.
  • Schlosser RJ; Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina, Charleston, SC, USA.
  • Senior BA; Department of Otolaryngology - Head and Neck Surgery, University of North Carolina, Chapel Hill, NC, USA.
  • Smith TL; Division of Rhinology and Sinus Surgery, Oregon Sinus Center, Oregon Health.
  • Tomazic PV; Department of Otorhinolaryngology, Medical University of Graz, Graz, Austria.
  • Zhang L; Department of Allergy, Beijing TongRen Hospital, Capital Medical University, Beijing, China and Department of Otolaryngology, Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China and Beijing Institute of Otolaryngology, Beijing Laboratory of Allergic Diseases,
  • Hopkins C; Department of Otolaryngology and Head Neck Surgery, Guys and St Thomas’ Hospital, London, UK.
Rhinology ; 61(6): 519-530, 2023 Dec 01.
Article em En | MEDLINE | ID: mdl-37804121
ABSTRACT

BACKGROUND:

Chronic rhinosinusitis (CRS) disease control is a global metric of disease status for CRS. While there is broad acceptance that it is an important treatment goal, there has been inconsistency in the criteria used to define CRS control. The objective of this study was to identify and develop consensus around essential criteria for assessment of CRS disease control.

METHODS:

Modified Delphi methodology consisting of three rounds to review a list of 24 possible CRS control criteria developed by a 12-person steering committee. The core authorship of the multidisciplinary EPOS 2020 guidelines was invited to participate.

RESULTS:

Thirty-two individuals accepted the invitation to participate and there was no dropout of participants throughout the entire study (3 rounds). Consensus essential criteria for assessment of CRS control were overall symptom severity, need for CRS-related systemic corticosteroids in the prior 6 months, severity of nasal obstruction, and patient-reported CRS control. Near-consensus items were nasal endoscopy findings, severity of smell loss, overall quality of life, impairment of normal activities and severity of nasal discharge. Participants’ comments provided insights into caveats of, and disagreements related to, near-consensus items.

CONCLUSIONS:

Overall symptom severity, use of CRS-related systemic corticosteroids, severity of nasal obstruction, and patient-reported CRS control are widely agreed upon essential criteria for assessment of CRS disease control. Consideration of near-consensus items to assess CRS control should be implemented with their intrinsic caveats in mind. These identified consensus CRS control criteria, together with evidence-based support, will provide a foundation upon which CRS control criteria with wide-spread acceptance can be developed.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sinusite / Obstrução Nasal / Rinite / Pólipos Nasais Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sinusite / Obstrução Nasal / Rinite / Pólipos Nasais Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article